Table 1. Association of AIB1 expression with clinicopathological characteristics of 146 patients with non-muscle-invasive BC.
|
AIB1 protein | ||
---|---|---|---|
Characteristics | Cases | Overexpression (%) | P-value |
Gender |
|
|
0.700 |
Male | 117 | 36 (30.8%) | |
Female |
29 |
10 (34.5%) |
|
Age (years) |
|
|
0.596 |
⩽60 | 65 | 19 (29.2%) | |
>60 |
81 |
27 (33.3%) |
|
pT status |
|
|
0.751 |
pTa | 101 | 31 (30.7%) | |
pT1 |
45 |
15 (33.3%) |
|
WHO grade |
|
|
0.394 |
Low grade | 93 | 27 (29.0%) | |
High grade |
53 |
19 (35.8%) |
|
Tumour multiplicity |
|
|
0.321 |
Unifocal | 88 | 25 (28.4%) | |
Multifocal |
58 |
21 (36.2%) |
|
Tumour size |
|
|
0.119 |
⩽2.0 cm | 71 | 18 (25.3%) | |
>2.0 cm | 75 | 28 (37.3%) |
Abbreviations: pT=pathological T(TNM); WHO=World Health Organisation.